MIRA PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mira Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2022 to Q3 2024.
  • Mira Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -337 %, a 22.6% increase year-over-year.
  • Mira Pharmaceuticals, Inc. annual Return On Equity for 2023 was -403 %, a 54.7% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -337 +98.3 +22.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -286 -2.94K -111% Apr 1, 2024 Jun 30, 2024
Q1 2024 -294 -3.11K -110% Jan 1, 2024 Mar 31, 2024
Q4 2023 -403 +486 +54.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -436 Jul 1, 2023 Sep 30, 2023
Q2 2023 2.66K Apr 1, 2023 Jun 30, 2023
Q1 2023 2.82K Jan 1, 2023 Mar 31, 2023
Q4 2022 -888 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.